Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...
With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...
REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...
The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...
Myriad Genetics, Inc. MYGN recently announced a joint effort with Ultima Genomics, Inc. to explore its UG 100 sequencing platform and ppmSeq technology. The collaboration will help advance the company ...
The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...
About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s risk of developing opioid use disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results